Loading…
rxshopmd.com, operating from Cyprus, unlawfully sold unapproved and misbranded drug products to U.S. consumers via its website, including products claiming to treat, prevent, diagnose, or cure COVID-19 and HIV in violation of sections 505(a) and 502 of the Federal Food, Drug, and Cosmetic Act. The FDA identified these violations during a website review on December 13, 2021, emphasizing heightened enforcement urgency given the ongoing COVID-19 public health emergency declared by HHS and the President. The company's unapproved drugs lacked FDA safety and effectiveness oversight, posing inherent risks to consumers purchasing these products over the internet.